Atossa Therapeutics
ATOS
#9237
Rank
โ‚ฌ88.67 M
Marketcap
0,69ย โ‚ฌ
Share price
5.24%
Change (1 day)
-39.44%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ0.56 M-69.52%
2024โ‚ฌ1.86 M265.91%
2023โ‚ฌ0.5 M-93.57%
2022โ‚ฌ7.92 M-92.88%
2021โ‚ฌ0.11 B731.9%
2020โ‚ฌ13.37 M-10.09%
2019โ‚ฌ14.87 M138.47%
2018โ‚ฌ6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚ฌ54.31 Mโ‚ฌ94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ14.74 Mโ‚ฌ33.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ22.12 Mโ‚ฌ37.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ0 Mโ‚ฌ0.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ0.05 Mโ‚ฌ13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ0.77 Mโ‚ฌ3.68 M๐Ÿ‡บ๐Ÿ‡ธ USA